Navigation Links
Scots link-up with China to boost genetic research
Date:7/24/2012

Research in the growing field of genomics which could lead to a new generation of personalised medical treatments will be boosted by an initiative that brings together scientific expertise from China and Edinburgh.

A memorandum of understanding signed between the University of Edinburgh and BGI, the world's largest genomics organisation, will aim to build on both institutions' strengths in genomics.

It will aim to enhance researchers' scientific understanding of the building blocks with which people and other living organisms are made.

The partnership will lead to an expansion of genomics research in Edinburgh, including analysing hereditary information encoded in our DNA, which could help assess risks for particular diseases.

It comes at a time of increasing interest in how better understanding of genes, through DNA sequencing facilities, will help to develop personalised medicines.

Genomics also plays an important role in looking at how livestock can be bred with resistance to diseases to help produce food sustainably for a growing global population.

The agreement between the University of Edinburgh and BGI will explore how research at three genomics facilities in Edinburgh GenePool Genomics Facility in the School of Biological Sciences, ARK Genomics at the Roslin Institute and the Genetics Core at the Wellcome Trust Clinical Research Facility and the Institute of Genetics and Molecular Medicine could be enhanced through collaboration with BGI.

As one of the world's largest genomics organisations, BGI has developed an integrative structure of research innovation, platform development and industrial application. BGI is actively building links with research leaders all over the world, with the aim of promoting the advancement of innovative biology research, molecular breeding, healthcare and related fields.

Quotes:

Professor Mark Blaxter, Director of the School of Biological
'/>"/>

Contact: Jia Liu
liujia@genomics.cn
BGI Shenzhen
Source:Eurekalert

Page: 1 2

Related biology news :

1. China Botanic Receives Patent on its Schisandra Lignin Extraction Method
2. Atmospheric scientists release first bottom-up estimates of Chinas CO2 emissions
3. China poised to accept first-ever non-animal test method for cosmetics
4. Polluting China for the sake of economic growth
5. NJIT, Chinas Bengbu Glass Institute sign agreement for R&D, training
6. Whats in a surname? New study explores what the evolution of names reveals about China
7. Is rainfall a greater threat to Chinas agriculture than warming?
8. WileyChina.com - Now Featuring Bespoke Pages for China’s Life Scientists
9. Tamarisk biocontrol efforts get evolutionary boost
10. The genomics symposium to boost the further development of cancer research
11. Boosting blood system protein complex protects against radiation toxicity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2015)... HAUPPAUGE, N.Y. , Aug. 19, 2015 /PRNewswire/ ... announced that it has entered into a Definitive ... intellectual property, of iris authentication market leader EyeLock ... transaction, VOXX will have a controlling interest in ... is subject to completion of due diligence.  Expanding ...
(Date:8/12/2015)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is proud to announce that iMedNet ... platform, has led the way to significant and unprecedented ...   Q2 2015 and Q1 2015 were, respectively, the ... sold in the company,s 15 year history.  In addition, ...
(Date:8/11/2015)... , August 11, 2015 Today, ZUK ... Already received as well as expected revenues in 2015 that relate ... FPC,s communicated revenue guidance of approximately 2,200 MSEK for 2015. ... is a prominent smartphone manufacturer in ... ZUK selected FPC1 155 for ...
Breaking Biology News(10 mins):VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5MedNet Solutions Experiences Explosive Corporate Growth 2FPC's Touch Fingerprint Sensor FPC1155 in ZUK's Smartphone Z1 2
... drug currently used to treat breast cancer, also kills a ... The findings, which could lead to new treatments for ... in mBio , the online open-access journal of the ... stage for additional animal studies to see if tamoxifen can ...
... Translational Genomics Research Institute (TGen) has uncovered possible genetic origins ... a first-of-its-kind study published in the scientific journal PLOS ... TGen now can be used to identify potential new methods ... patients in the U.S. each year whose cancer spreads from ...
... over the next century, plants and animals will need to ... new study provides an innovative global map of where species ... a changing climate. The findings appear in the science journal ... Santa Barbara National Center for Ecological Analysis and Synthesis (NCEAS) ...
Cached Biology News:Breast cancer drug fights fungal disease 2TGen study uncovers possible genetic markers in breast cancer that spreads to the brain 2Maps show expected redistribution of global species due to climate change 2Maps show expected redistribution of global species due to climate change 3
(Date:9/2/2015)... -- Biovista Inc. is glad to announce ... science challenge, a global competition hosted by the Rare ... the latest life science innovations and technologies. ... capability to support Steven Laffoon and his ... Niemann-Pick Disease Type A (NPA), a rare and fatal ...
(Date:9/2/2015)... 2015 Australian prostate cancer technology company Minomic ... prize recognising ,outstanding, science that uses its patented antibody. ... a novel prostate cancer diagnostic test known as MiCheck® ... taking out the peer-reviewed Australian Museum Eureka Science Prize ... This prize is awarded for ground breaking research ...
(Date:9/2/2015)... BioLight Life Sciences Investments ... a firm that invests in, manages and commercializes ... today that presentations highlighting its IOPtiMate™ system for ... the Ophthalmology Futures European Forum and the XXXIII ... Refractive Surgeons ("ESCRS"), both taking place in the ...
(Date:9/2/2015)... ... September 02, 2015 , ... Advancing in medical imaging ... vital sign monitoring in ICU to 3D skull printing analysis for Neurosurgery, ONYX ... clinical decisions with simultaneous access to high precision medical images and electronic health ...
Breaking Biology Technology:Biovista Sponsors Wylder Nation Foundation's Research on Acid Sphingomyelinase Deficiency 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 2Prostate Cancer Company Minomic Wins Prestigious Eureka Science Prize 3Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 2Presentations to Highlight BioLight's IOPtiMate[TM] System at Upcoming European Ophthalmology Conferences 3Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 2Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 3
... ... and services , ... CA (PRWEB) November 13, 2009 -- Applied Technology Holdings, Inc., today announced the 3 directors ... of directors. , , ,Jay A. Shears will remain as chairman of the ...
... go to his or her head: It also provokes a ... serve as a permanent record of each exposure. With ... the National Institute of Drug Abuse (NIDA) an interdisciplinary team ... will attempt to determine whether an individual,s white blood cells ...
... 11 /PRNewswire-Asia-FirstCall/ -- China Pharma,Holdings, Inc. ("China Pharma") (NYSE/AMEX: ... today announced financial,results for the third quarter ended September 30, ... Highlights, -- Revenue increased 23.1% to $15.5 ... third quarter of 2008;, -- ...
Cached Biology Technology:Applied Technology Holdings, Inc. Announces Board of Directors 2Interdisciplinary research team developing novel drug detection technology 2Interdisciplinary research team developing novel drug detection technology 3Interdisciplinary research team developing novel drug detection technology 4China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 2China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 3China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 4China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 5China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 6China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 7China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 8China Pharma Holdings, Inc. Reports Third Quarter 2009 Financial Results and Corporate Updates 9
... DNA Kit enables efficient extraction of DNA fragments from ... agarose gels. The procedure uses GelMelt solution to dissolve ... to a silica membrane in a spin column format. ... in low-salt buffer. Each spin column can bind up ...
... is ideal for the ... (1D electrophoresis, 2D electrophoresis, ... Pharmacokinetics & Toxicology (whole ... chromatography); Physical and Material ...
BlotGel application pool -see Blotters (Semi-Dry) for more info...
When added to either StemSep CD4+ or CD8+ T Cell Enrichment cocktails, human HLA-DR TAC is designed to deplete human HLA-DR from samples to isolate resting CD4+ or CD8+ T cells....
Biology Products: